Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 370 of 6351
-
New Non-Surgical heart valve could help thousands with leaky tricuspid
Disease control Recruiting nowThis clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New drug targets breast cancer brain tumors in early trial
Disease control Not yet recruitingThis is a multi-site prospective single-arm open-label phase 2 clinical trial including 20 participants with metastatic TNBC and active brain metastases to be treated with sacituzumab tirumotecan 4 mg/kg IV on Days 1, and 15 of every 28-day cycle until disease progression, unacce…
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New BTK blocker aims to outsmart drug resistance in elderly CLL patients
Disease control Recruiting nowThis phase II trial studies how well pirtobrutinib works in treating elderly patients with chronic lymphocytic leukemia (CLL). Bruton tyrosine kinase (BTK) inhibitors such as ibrutinib, acalabrutinib, and zanubrutinib work by blocking the action of the BTK protein that signals ca…
Phase 2 • Sponsor: Jennifer Woyach • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New drug duo targets Hard-to-Treat colorectal cancer
Disease control Not yet recruitingThe purpose of this study is find out whether the combination of trastuzumab deruxtecan (T-DXd) and cetuximab is an effective treatment for participants with metastatic and/or unresectable colorectal cancer that expresses low levels of HER2 and that has gotten worse after receivi…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Double attack on EGFR-Positive tumors: targeted drug plus immunotherapy combo tested
Disease control Recruiting nowThis phase II trial evaluates the combination of Becotatug Vedotin (MRG003), an EGFR-targeting ADC, and Pucotenlimab (HX008), a PD-1 inhibitor, in patients with high EGFR expressing advanced refractory solid tumors. The study is designed to assess clinical efficacy and safety, bu…
Phase 2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New drug cocktail aims to shrink Hard-to-Treat gut tumors
Disease control Not yet recruitingThis study is a single prospective, parallel, double-cohort, multicenter phase II clinical trial, aiming to evaluate the efficacy and safety of ivonescimab (AK112) combined with IP chemotherapy ± TACE in the first-line treatment of metastatic digestive system neuroendocrine cance…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a Two-Drug cocktail shrink Hard-to-Treat bile duct cancers?
Disease control Not yet recruitingThis is a prospective, single-arm, Phase II study evaluating sacituzumab tirumotecan combined with envafolimab in patients with TROP2-positive advanced biliary tract cancers who have progressed on first-line immunochemotherapy. Up to 28 eligible patients will be enrolled.After sc…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can a sound wave camera inside arteries save more legs?
Disease control Not yet recruitingChronic limb-threatening ischemia (CLTI) is a severe form of peripheral artery disease in which very poor blood flow in the arteries below the knee can cause rest pain, non-healing wounds, and even loss of the limb. It is often treated with endovascular therapy (EVT), a minimally…
Sponsor: Shin Kong Wu Ho-Su Memorial Hospital • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Ear stimulation may boost brain rewiring in babies with brain injury
Disease control Not yet recruitingThis study is for infants and toddlers between 8 and 24 months old who use one arm and/or hand differently following a perinatal brain injury. This is a time when investigators think they can best help improve how the brain controls movement. Investigators are testing whether the…
Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Could a monthly shot ease schizophrenia treatment?
Disease control Not yet recruitingThis study is to evaluate the pharmacokinetics (PK), safety and tolerability of Brexpiprazole, administered subcutaneously, in subjects with schizophrenia.
Phase 2/3 • Sponsor: Bostal Drug Delivery Co., Ltd • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Virtual worlds may dull the sting of burn care for children
Symptom relief Not yet recruitingBurn injuries are very painful for children, especially during dressing changes when the wound is cleaned and re-bandaged. This procedure, while necessary, can cause pain, fear, and distress that may make children afraid of future treatments. Virtual reality (VR) is a technology …
Sponsor: Mansoura University • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Mind over MS: could online therapy lift the fog of depression?
Symptom relief Not yet recruitingThis study will use a waiting list randomized controlled trial design with a mixed-methods research approach, including both quantitative and qualitative methods. Randomization helps minimize research bias and controls for participant and contextual factors that might otherwise m…
Phase 3 • Sponsor: Robert Simpson • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
A break from seizure pills: could less medication mean better living?
Disease control Recruiting nowThe main purpose of this study is to understand the effects of continuing versus discontinuing antiseizure medications after a period of seizure-freedom. Physician guidelines endorse that after a period of seizure-freedom, the risk of another seizure may be low enough to allow pa…
Phase 4 • Sponsor: University of Michigan • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Smartphone light sensor may spot when an irregular heartbeat fixes itself
Disease control Not yet recruitingThis study investigates whether a smartphone application that measures heart rhythm using light, a technique known as photoplethysmography or PPG, can accurately detect when the cardiac arrhythmia atrial fibrillation (AF) spontaneously terminates and the heart returns to normal s…
Sponsor: Ziekenhuis Oost-Limburg • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a pill make your blood deadly to malaria mosquitoes?
Prevention Not yet recruitingThis is a Phase 1b, single-cente, randomized, double-blind, placebo-controlled proof-of-concept study evaluating the safety, tolerability, pharmacokinetics and mosquitocidal activity of single oral doses of lotilaner in healthy, adult participants living in Mali.
Phase 1 • Sponsor: Medicines for Malaria Venture • Aim: Prevention
Last updated Aug 13, 2026 00:00 UTC
-
Can a Blood-Derived patch reduce complications in penile surgery?
Disease control Not yet recruitingHypospadias is an anomaly characterized by an ectopic ventral urethral meatus, and an incomplete or hooded prepuce. Its incidence is estimated at 1 in 200-300 live male births, with variations across populations and severity types. Successful hypospadias repair depends largely o…
Sponsor: Ain Shams University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a pain drug help you walk better with knee arthritis?
Symptom relief Not yet recruitingThe goal of this clinical trial is to examine the effects of duloxetine on walking ability and physical activity in patients with knee osteoarthritis. Researchers will compare duloxetine to a placebo (a look-alike substance that contains no drug) to see if duloxetine works to imp…
Phase 4 • Sponsor: Benedict Alter • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Can acupuncture soothe the mind and body in breast cancer?
Symptom relief Not yet recruitingThis study adopts a multicenter, pragmatic, umbrella randomized controlled trial design integrated with the shared decision-making (SDM) model. Patients are stratified into four subgroups based on their core psychosomatic symptom phenotypes (single symptom vs. multiple comorbid s…
Sponsor: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Can a Feather-Light penile monitor replace the uncomfortable gold standard?
Diagnosis Not yet recruitingThis study aims to evaluate the diagnostic performance of a novel intelligent flexible penile monitoring system for erectile dysfunction (ED). The current gold standard, RigiScan Plus, often causes discomfort and disrupts sleep due to its mechanical rings, leading to potential "f…
Sponsor: Bin Xu • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC
-
Can we map the course of a rare mitochondrial disease?
Knowledge-focused Not yet recruitingThe PIONEER study is a prospective, natural history study dedicated to characterizing the clinical progression of POLG-related disorders. The research aims to bridge the gap between genetic diagnosis and drug development by mapping how these rare mitochondrial conditions evolve o…
Sponsor: The POLG Foundation • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC